140 related articles for article (PubMed ID: 27524668)
1. Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequences.
Peterlik D; Stangl C; Bauer A; Bludau A; Keller J; Grabski D; Killian T; Schmidt D; Zajicek F; Jaeschke G; Lindemann L; Reber SO; Flor PJ; Uschold-Schmidt N
Brain Behav Immun; 2017 Jan; 59():79-92. PubMed ID: 27524668
[TBL] [Abstract][Full Text] [Related]
2. Relief from detrimental consequences of chronic psychosocial stress in mice deficient for the metabotropic glutamate receptor subtype 7.
Peterlik D; Stangl C; Bludau A; Grabski D; Strasser R; Schmidt D; Flor PJ; Uschold-Schmidt N
Neuropharmacology; 2017 Mar; 115():139-148. PubMed ID: 27188844
[TBL] [Abstract][Full Text] [Related]
3. Homer1/mGluR5 activity moderates vulnerability to chronic social stress.
Wagner KV; Hartmann J; Labermaier C; Häusl AS; Zhao G; Harbich D; Schmid B; Wang XD; Santarelli S; Kohl C; Gassen NC; Matosin N; Schieven M; Webhofer C; Turck CW; Lindemann L; Jaschke G; Wettstein JG; Rein T; Müller MB; Schmidt MV
Neuropsychopharmacology; 2015 Mar; 40(5):1222-33. PubMed ID: 25409593
[TBL] [Abstract][Full Text] [Related]
4. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
Lindemann L; Jaeschke G; Michalon A; Vieira E; Honer M; Spooren W; Porter R; Hartung T; Kolczewski S; Büttelmann B; Flament C; Diener C; Fischer C; Gatti S; Prinssen EP; Parrott N; Hoffmann G; Wettstein JG
J Pharmacol Exp Ther; 2011 Nov; 339(2):474-86. PubMed ID: 21849627
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Jaeschke G; Kolczewski S; Spooren W; Vieira E; Bitter-Stoll N; Boissin P; Borroni E; Büttelmann B; Ceccarelli S; Clemann N; David B; Funk C; Guba W; Harrison A; Hartung T; Honer M; Huwyler J; Kuratli M; Niederhauser U; Pähler A; Peters JU; Petersen A; Prinssen E; Ricci A; Rueher D; Rueher M; Schneider M; Spurr P; Stoll T; Tännler D; Wichmann J; Porter RH; Wettstein JG; Lindemann L
J Med Chem; 2015 Feb; 58(3):1358-71. PubMed ID: 25565255
[TBL] [Abstract][Full Text] [Related]
6. Blocking glutamate mGlu
Milanese M; Bonifacino T; Torazza C; Provenzano F; Kumar M; Ravera S; Zerbo AR; Frumento G; Balbi M; Nguyen TPN; Bertola N; Ferrando S; Viale M; Profumo A; Bonanno G
Br J Pharmacol; 2021 Sep; 178(18):3747-3764. PubMed ID: 33931856
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
Lindemann L; Porter RH; Scharf SH; Kuennecke B; Bruns A; von Kienlin M; Harrison AC; Paehler A; Funk C; Gloge A; Schneider M; Parrott NJ; Polonchuk L; Niederhauser U; Morairty SR; Kilduff TS; Vieira E; Kolczewski S; Wichmann J; Hartung T; Honer M; Borroni E; Moreau JL; Prinssen E; Spooren W; Wettstein JG; Jaeschke G
J Pharmacol Exp Ther; 2015 Apr; 353(1):213-33. PubMed ID: 25665805
[TBL] [Abstract][Full Text] [Related]
8. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
9. Chronic psychosocial stress results in sensitization of the HPA axis to acute heterotypic stressors despite a reduction of adrenal in vitro ACTH responsiveness.
Uschold-Schmidt N; Nyuyki KD; Füchsl AM; Neumann ID; Reber SO
Psychoneuroendocrinology; 2012 Oct; 37(10):1676-87. PubMed ID: 22444976
[TBL] [Abstract][Full Text] [Related]
10. Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5.
Fuxe K; Borroto-Escuela DO
Expert Opin Investig Drugs; 2015; 24(9):1247-60. PubMed ID: 26219727
[TBL] [Abstract][Full Text] [Related]
11. Blocking Metabotropic Glutamate Receptor Subtype 7 via the Venus Flytrap Domain Promotes a Chronic Stress-Resilient Phenotype in Mice.
Estrela KAR; Senninger L; Arndt J; Kabas M; Schmid F; Dillmann L; Auer S; Stepfer T; Flor PJ; Uschold-Schmidt N
Cells; 2022 Jun; 11(11):. PubMed ID: 35681512
[TBL] [Abstract][Full Text] [Related]
12. Behavioural consequences of two chronic psychosocial stress paradigms: anxiety without depression.
Slattery DA; Uschold N; Magoni M; Bär J; Popoli M; Neumann ID; Reber SO
Psychoneuroendocrinology; 2012 May; 37(5):702-14. PubMed ID: 21962377
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic psychosocial stress-induced by subordinate colony (CSC) housing on brain neuronal activity patterns in mice.
Singewald GM; Nguyen NK; Neumann ID; Singewald N; Reber SO
Stress; 2009 Jan; 12(1):58-69. PubMed ID: 19116889
[TBL] [Abstract][Full Text] [Related]
14. Chronic subordinate colony housing (CSC) as a model of chronic psychosocial stress in male rats.
Nyuyki KD; Beiderbeck DI; Lukas M; Neumann ID; Reber SO
PLoS One; 2012; 7(12):e52371. PubMed ID: 23300653
[TBL] [Abstract][Full Text] [Related]
15. Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
Arsova A; Møller TC; Vedel L; Hansen JL; Foster SR; Gregory KJ; Bräuner-Osborne H
Mol Pharmacol; 2020 Jul; 98(1):49-60. PubMed ID: 32358164
[TBL] [Abstract][Full Text] [Related]
16. Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies.
Bennett KA; Sergeev E; MacSweeney CP; Bakker G; Cooper AE
J Pharmacol Exp Ther; 2021 Apr; 377(1):157-168. PubMed ID: 33541889
[TBL] [Abstract][Full Text] [Related]
17. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.
Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ
J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377
[TBL] [Abstract][Full Text] [Related]
18. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
[TBL] [Abstract][Full Text] [Related]
19. Stress resilience: a low-anxiety genotype protects male mice from the consequences of chronic psychosocial stress.
Füchsl AM; Neumann ID; Reber SO
Endocrinology; 2014 Jan; 155(1):117-26. PubMed ID: 24169562
[TBL] [Abstract][Full Text] [Related]
20. mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice.
Lee KM; Coelho MA; Class MA; Szumlinski KK
Drug Alcohol Depend; 2018 Mar; 184():1-11. PubMed ID: 29324247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
